Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. Zusätzlich bieten wir Ihnen Junctional Adhesion Molecule 2 Proteine (22) und Junctional Adhesion Molecule 2 Kits (8) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 142 products:
Human Polyclonal JAM2 Primary Antibody für ELISA - ABIN450060
Kim, Zhang, Yamagata, Meister, Sanes: Molecular identification of a retinal cell type that responds to upward motion. in Nature 2008
Human Polyclonal JAM2 Primary Antibody für ELISA, WB - ABIN4327905
Ueki, Iwasawa, Ishikawa, Sawa: Expression of junctional adhesion molecules on the human lymphatic endothelium. in Microvascular research 2008
The developmental expression pattern of jam (zeige F11R Antikörper)-b2 suggests that it may contribute different properties to extraocular muscles, jaw muscles, and pectoral fins.
results indicate that Jam1a-Jam2a interactions facilitate the transduction of requisite Notch (zeige NOTCH1 Antikörper) signals from the somite to the precursors of HSCs, and that these events occur well before formation of the dorsal aorta
interaction between Jamb and Jamc (zeige JAM3 Antikörper) expressed by neighbouring cells is essential for fusion.
JAM-B/JAM-C (zeige JAM3 Antikörper) mediated interaction between endothelial cells and stellate cells stabilizes vessel walls and may control the sinusoidal diameter.
JAM-B is an as yet underappreciated trophoblast lineage-specific protein, which is modulated via the progesterone receptor (zeige PGR Antikörper) and shows unique strain-specific kinetics.
identify neuronal junction adhesion molecule 2 (JAM2) as an inhibitory myelin-guidance molecule.
JAM-B expression was detected in de novo-formed blood vessels of tumors.
TGF-beta3 (zeige TGFB3 Antikörper) significantly downregulates JAM-B expression via post-transcriptional and post-translational modulation and results in the disruption of BTB and apical ES.
Function of Jam-B/Jam-C (zeige JAM3 Antikörper) interaction in homing and mobilization of human and mouse hematopoietic stem and progenitor cells.
Data show that junctional adhesion molecule-B (JAM-B) expressed by endothelial cells contributes to murine B16 melanoma cells metastasis through its interaction with junctional adhesion molecule-C (JAM-C (zeige JAM3 Antikörper)) on tumor cells.
Jam2 has a role in the interaction between hatched blastocyst and receptive uterus.
JAM-B is an active player in the maintenance of the bone marrow stromal microenvironment.
Results suggest a role for junctional adhesion molecule-2 (JAM-2) in facilitating transmigration in endothelial cells.
this review briefly focuses on what is currently known about the structure, function, and mechanism of JAM-B, with particular emphasis on cancer. [review]
JAM-2 may function as a putative tumour suppressor in the progression and metastasis of colorectal cancer
These data brought new evidences for the role of JAM2 and JAM3 (zeige JAM3 Antikörper) in progression of gastric adenocarcinoma
Results suggest a role for junctional adhesion molecule-2 (JAM-2) in facilitating transmigration in endothelial cells
Examine JAM-2 expression in normal/inflammed lymphatic endothelium.
This gene belongs to the immunoglobulin superfamily, and the junctional adhesion molecule (JAM) family. The protein encoded by this gene is a type I membrane protein that is localized at the tight junctions of both epithelial and endothelial cells. It acts as an adhesive ligand for interacting with a variety of immune cell types, and may play a role in lymphocyte homing to secondary lymphoid organs. Alternatively spliced transcript variants have been found for this gene.
junctional adhesion molecule B
, junctional adhesion molecule 2
, junction adhesion molecule B
, junction cell adhesion molecule 2
, vascular endothelial junction-associated molecule
, junction adhesion molecule 2